Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Translational precision medicine: an industry perspective.
Hartl D, de Luca V, Kostikova A, Laramie J, Kennedy S, Ferrero E, Siegel R, Fink M, Ahmed S, Millholland J, Schuhmacher A, Hinder M, Piali L, Roth A. Hartl D, et al. Among authors: hinder m. J Transl Med. 2021 Jun 5;19(1):245. doi: 10.1186/s12967-021-02910-6. J Transl Med. 2021. PMID: 34090480 Free PMC article. Review.
The Art of Virtualizing Pharma R&D.
Schuhmacher A, Gassmann O, Kuss M, Hinder M. Schuhmacher A, et al. Among authors: hinder m. Drug Discov Today. 2019 Nov;24(11):2105-2107. doi: 10.1016/j.drudis.2019.07.004. Epub 2019 Jul 16. Drug Discov Today. 2019. PMID: 31323393 No abstract available.
The upside of being a digital pharma player.
Schuhmacher A, Gatto A, Hinder M, Kuss M, Gassmann O. Schuhmacher A, et al. Among authors: hinder m. Drug Discov Today. 2020 Sep;25(9):1569-1574. doi: 10.1016/j.drudis.2020.06.002. Epub 2020 Jun 15. Drug Discov Today. 2020. PMID: 32554063
The present and future of project management in pharmaceutical R&D.
Schuhmacher A, Gassmann O, Hinder M, Kuss M. Schuhmacher A, et al. Among authors: hinder m. Drug Discov Today. 2021 Jan;26(1):1-4. doi: 10.1016/j.drudis.2020.07.020. Epub 2020 Jul 31. Drug Discov Today. 2021. PMID: 32745523 No abstract available.
Open innovation: A paradigm shift in pharma R&D?
Schuhmacher A, Gassmann O, Bieniok D, Hinder M, Hartl D. Schuhmacher A, et al. Among authors: hinder m. Drug Discov Today. 2022 Sep;27(9):2395-2405. doi: 10.1016/j.drudis.2022.05.018. Epub 2022 May 26. Drug Discov Today. 2022. PMID: 35643258
R&D efficiency of leading pharmaceutical companies - A 20-year analysis.
Schuhmacher A, Wilisch L, Kuss M, Kandelbauer A, Hinder M, Gassmann O. Schuhmacher A, et al. Among authors: hinder m. Drug Discov Today. 2021 Aug;26(8):1784-1789. doi: 10.1016/j.drudis.2021.05.005. Epub 2021 May 19. Drug Discov Today. 2021. PMID: 34022459 Review.
157 results